IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Esperion Therapeutics Inc NE

CUSIP: 29664WAB1 | 43 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2025

Pentwater Capital Management LP10,861,000
0.1% of portfolio›$10.8M
DeepCurrents Investment Group LLC8,396,000
0.2% of portfolio›$8.3M
PenderFund Capital Management Ltd.3,000,000
0.5% of portfolio›$3.0M
Oaktree Capital Management LP2,114,000
0.0% of portfolio›$2.1M
Jefferies Financial Group Inc.1,751,000
0.0% of portfolio›$1.7M
Russell Investments Group, Ltd.1,687,000
0.0% of portfolio›$1.7M
Saranac Partners Ltd500,000
0.1% of portfolio›$501.3K
Zazove Associates LLC375,000
0.0% of portfolio›$373.0K
Context Capital Management, LLC12,440
0.4% of portfolio›$12.4M
StyleTurnoverLocationFiled
Pentwater Capital Management LP
10,861,000$10.8M0.1%ValueVery HighNaples, FL2025-11-14
DeepCurrents Investment Group LLC
8,396,000$8.3M0.2%GARPHighNew York, NY2025-11-14
PenderFund Capital Management Ltd.
3,000,000$3.0M0.5%Deep ValueVery HighVancouver, UAE2025-11-14
Oaktree Capital Management LP
2,114,000$2.1M0.0%YieldMediumLos Angeles, CA2025-11-13
Jefferies Financial Group Inc.
1,751,000$1.7M0.0%CoreVery HighNew York, NY2025-11-13
Russell Investments Group, Ltd.
1,687,000$1.7M0.0%CoreLowSeattle, WA2025-11-13
Saranac Partners Ltd
500,000$501.3K0.1%CoreHighLondon, United Kingdom2025-12-05
Zazove Associates LLC
375,000$373.0K0.0%YieldMediumIncline Village, NV2025-10-17
Context Capital Management, LLC
12,440$12.4M0.4%GARPHighGreenwich, CT2025-11-12